USANA Health Sciences (NYSE:USNA) Cut to Hold at Wall Street Zen

Wall Street Zen lowered shares of USANA Health Sciences (NYSE:USNA) from a buy rating to a hold rating in a research report sent to investors on Saturday.

USNA has been the subject of several other research reports. Weiss Ratings restated a “sell (d+)” rating on shares of USANA Health Sciences in a research report on Wednesday, October 8th. Zacks Research lowered shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 22nd. Three investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average price target of $36.00.

USANA Health Sciences Price Performance

USNA stock opened at $20.58 on Friday. USANA Health Sciences has a 1-year low of $19.88 and a 1-year high of $41.83. The firm has a fifty day moving average price of $29.46 and a two-hundred day moving average price of $29.26. The firm has a market cap of $375.91 million, a price-to-earnings ratio of 11.43, a PEG ratio of 0.64 and a beta of 0.61.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Thursday, October 9th. The company reported $0.56 EPS for the quarter. The business had revenue of $200.22 million during the quarter. USANA Health Sciences had a net margin of 3.79% and a return on equity of 9.48%. USANA Health Sciences has set its Q3 2025 guidance at -0.150–0.150 EPS. As a group, analysts expect that USANA Health Sciences will post 2.45 EPS for the current fiscal year.

Insider Transactions at USANA Health Sciences

In other USANA Health Sciences news, insider David Mulham Mulham sold 3,515 shares of the company’s stock in a transaction dated Wednesday, July 30th. The shares were sold at an average price of $30.26, for a total value of $106,363.90. Following the completion of the sale, the insider directly owned 9,260 shares of the company’s stock, valued at approximately $280,207.60. This represents a 27.51% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gilbert A. Fuller sold 1,058 shares of the company’s stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $29.10, for a total transaction of $30,787.80. The disclosure for this sale can be found here. 0.63% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On USANA Health Sciences

A number of institutional investors and hedge funds have recently bought and sold shares of USNA. US Bancorp DE increased its holdings in USANA Health Sciences by 13.1% in the first quarter. US Bancorp DE now owns 4,611 shares of the company’s stock worth $124,000 after buying an additional 535 shares during the last quarter. Exchange Traded Concepts LLC increased its holdings in USANA Health Sciences by 7.1% in the first quarter. Exchange Traded Concepts LLC now owns 9,184 shares of the company’s stock worth $248,000 after buying an additional 606 shares during the last quarter. Creative Planning grew its holdings in USANA Health Sciences by 3.2% during the second quarter. Creative Planning now owns 20,051 shares of the company’s stock valued at $612,000 after purchasing an additional 613 shares during the last quarter. Quantbot Technologies LP grew its holdings in USANA Health Sciences by 19.5% during the second quarter. Quantbot Technologies LP now owns 3,957 shares of the company’s stock valued at $121,000 after purchasing an additional 646 shares during the last quarter. Finally, PNC Financial Services Group Inc. grew its holdings in USANA Health Sciences by 339.6% during the first quarter. PNC Financial Services Group Inc. now owns 998 shares of the company’s stock valued at $27,000 after purchasing an additional 771 shares during the last quarter. 54.25% of the stock is owned by institutional investors and hedge funds.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.